TY  - GEN
AU  - Abraham,Ivo
AU  - Han,Lucy
AU  - Sun,Diana
AU  - MacDonald,Karen
AU  - Aapro,Matti
TI  - Cost savings from anemia management with biosimilar epoetin alfa and increased access to targeted antineoplastic treatment: a simulation for the EU G5 countries
SN  - 1744-8301
PY  - 2015///0420
KW  - Anemia
KW  - chemically induced
KW  - Antibodies, Monoclonal, Humanized
KW  - economics
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Agents
KW  - adverse effects
KW  - Bevacizumab
KW  - Biosimilar Pharmaceuticals
KW  - therapeutic use
KW  - Drug Costs
KW  - Epoetin Alfa
KW  - Erythropoietin
KW  - European Union
KW  - Hematinics
KW  - Humans
KW  - Models, Economic
KW  - Neoplasms
KW  - drug therapy
KW  - Recombinant Proteins
KW  - Rituximab
KW  - Trastuzumab
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.2217/fon.14.43
ER  -